title: Triggered release of therapeutic antibodies from nanodiamond complexes.
abstract: Recent reports have revealed that detonation nanodiamonds (NDs) can serve as efficient, biocompatible, and versatile drug delivery platforms. Consequently, further investigations exploring additional therapeutic applications are warranted. Current limitations associated with the non-specific nature of intravenous drugs limit the potential of certain pharmacological agents. One such treatment that could benefit from a stable delivery platform is antibody (Ab) therapy. Determination of Ab adsorption and desorption to a ND surface was subsequently examined using the transforming growth factor β (TGF-β) antibody as a model therapeutic. ND-Ab complexes were found to be stable in water through enzyme-linked immunosorbent assays (ELISAs), UV-vis spectroscopy and TEM, with no Ab released after ten days. Released Abs were detected in extreme pH solutions (3.5), DMEM (+) serum with pH levels ranging from 4 to 10.5, and inorganic saline solutions. Preserved activity of Abs released in DMEM (+) serum was confirmed using an ELISA. These results suggest ND-Ab complexes are synthesized and stabilized in water and are triggered to release active Abs upon exposure to physiological conditions.
authors: Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
authors: Adrienne H
authors: AH
authors: Smith
authors: Erik M
authors: EM
authors: Robinson
authors: Xue-Qing
authors: XQ
authors: Zhang
authors: Edward K
authors: EK
authors: Chow
authors: Yang
authors: Y
authors: Lin
authors: Eiji
authors: E
authors: Osawa
authors: Jianzhong
authors: J
authors: Xi
authors: Dean
authors: D
authors: Ho
references: Nat Nanotechnol. 2007 Dec;2(12):751-60
references: 18654426
references: Sci Transl Med. 2011 Mar 9;3(73):73ra21
references: 21389265
references: Nat Rev Drug Discov. 2007 May;6(5):349-56
references: 17431406
references: J Phys Chem B. 2007 Jan 11;111(1):2-7
references: 17201422
references: Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11600-5
references: 16087878
references: ACS Nano. 2009 Jul 28;3(7):2016-22
references: 19534485
references: Nat Biotechnol. 2005 Sep;23(9):1147-57
references: 16151408
references: Nat Rev Drug Discov. 2004 Dec;3(12):1011-22
references: 15573100
references: ACS Nano. 2009 Sep 22;3(9):2609-16
references: 19719152
references: Biomaterials. 2009 Oct;30(29):5720-8
references: 19635632
references: Int J Pharm. 2002 Sep 5;244(1-2):59-72
references: 12204565
references: J Am Chem Soc. 2009 Apr 8;131(13):4594-5
references: 19290627
references: Adv Drug Deliv Rev. 2002 Oct 18;54(8):1145-55
references: 12384312
references: BioDrugs. 2004;18(2):121-39
references: 15046527
references: Transplantation. 2005 Aug 27;80(4):457-65
references: 16123718
references: Nanotechnology. 2005 Jul;16(7):S484-91
references: 21727469
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Aug 5;822(1-2):54-60
references: 15982935
references: Langmuir. 2004 Jul 6;20(14):5879-84
references: 16459604
references: Nano Lett. 2007 Nov;7(11):3305-14
references: 17918903
references: Immunol Today. 2000 Aug;21(8):403-10
references: 10916144
references: ACS Nano. 2008 Jan;2(1):33-40
references: 19206545
references: ACS Nano. 2008 Feb;2(2):203-12
references: 19206620
references: Invest New Drugs. 2003 Feb;21(1):21-32
references: 12795527
references: Chemistry. 2008;14(5):1382-90
references: 18033700
references: Nature. 2004 Apr 1;428(6982):487-92
references: 15057821